{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:22:30Z","timestamp":1789521750367,"version":"build-2803163510"},"reference-count":30,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,11,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The outcome of various osteoprogenitor-cell transplantation protocols was assessed using Col1a1-GFP reporter transgenic mice. The model requires the recipient mice to undergo lethal total body irradiation (TBI) followed by rescue with whole bone marrow. When the mice are rescued with total bone marrow from a Col1a1-GFP transgenic mouse, green fluorescence protein (GFP)-positive donor cells can be observed on most endosteal and trabecular bone surfaces. Although the cells express an osteoblast-restricted GFP, they fail to progress to osteocytes, do not form a mineralized matrix, and do not generate bone nodules in vitro. However when calvarial progenitor cells derived from the same transgenic mice are injected into the bone marrow space, osteogenesis by the donor cells is observed. Using different GFP colors that distinguish the donor and recipient osteoblasts, commingling of the 2 cells types is observed along the mineralizing osteoblast surface as well as within the osteocyte population of the endosteal bone. Despite the ability of the injected progenitor cells to produce bone within the injected bone, they lack the ability to form mineralized bone nodules when explanted to primary osteoblast culture. These reagents and imaging protocols will be useful in evaluating other cells having a better progenitor potential than calvarial-derived stromal cells.<\/jats:p>","DOI":"10.1182\/blood-2005-02-0582","type":"journal-article","created":{"date-parts":[[2005,8,5]],"date-time":"2005-08-05T00:43:53Z","timestamp":1123202633000},"page":"3650-3657","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":43,"title":["Heterogeneity of engrafted bone-lining cells after systemic and local transplantation"],"prefix":"10.1182","volume":"106","author":[{"given":"Liping","family":"Wang","sequence":"first","affiliation":[{"name":"From the Department of Genetics and Developmental Biology, University of Connecticut Health Center, Farmington, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaling","family":"Liu","sequence":"additional","affiliation":[{"name":"From the Department of Genetics and Developmental Biology, University of Connecticut Health Center, Farmington, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zana","family":"Kalajzic","sequence":"additional","affiliation":[{"name":"From the Department of Genetics and Developmental Biology, University of Connecticut Health Center, Farmington, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Jiang","sequence":"additional","affiliation":[{"name":"From the Department of Genetics and Developmental Biology, University of Connecticut Health Center, Farmington, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Rowe","sequence":"additional","affiliation":[{"name":"From the Department of Genetics and Developmental Biology, University of Connecticut Health Center, Farmington, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021216233162500_REF1","doi-asserted-by":"crossref","unstructured":"Hou Z, Nguyen Q, Frenkel B, et al. Osteoblast-specific gene expression after transplantation of marrow cells: implications for skeletal gene therapy. Proc Natl Acad Sci U S A. 1999;96: 7294-7299.","DOI":"10.1073\/pnas.96.13.7294"},{"key":"2020021216233162500_REF2","doi-asserted-by":"crossref","unstructured":"Nilsson SK, Dooner MS, Weier HU, et al. Cells capable of bone production engraft from whole bone marrow transplants in nonablated mice. J Exp Med. 1999;189: 729-734.","DOI":"10.1084\/jem.189.4.729"},{"key":"2020021216233162500_REF3","doi-asserted-by":"crossref","unstructured":"Olmsted-Davis EA, Gugala Z, Camargo F, et al. Primitive adult hematopoietic stem cells can function as osteoblast precursors. Proc Natl Acad Sci U S A. 2003;100: 15877-15882.","DOI":"10.1073\/pnas.2632959100"},{"key":"2020021216233162500_REF4","doi-asserted-by":"crossref","unstructured":"Pereira RF, O'Hara MD, Laptev AV, et al. Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proc Natl Acad Sci U S A. 1998;95: 1142-1147.","DOI":"10.1073\/pnas.95.3.1142"},{"key":"2020021216233162500_","doi-asserted-by":"crossref","unstructured":"Onyia JE, Clapp DW, Long H, Hock JM. Osteoprogenitor cells as targets for ex vivo gene transfer. J Bone Miner Res. 1998;13: 20-30.","DOI":"10.1359\/jbmr.1998.13.1.20"},{"key":"2020021216233162500_","doi-asserted-by":"crossref","unstructured":"Niyibizi C, Wallach CJ, Mi Z, Robbins PD. Approaches for skeletal gene therapy. Crit Rev Eukaryot Gene Expr. 2002;12: 163-173.","DOI":"10.1615\/CritRevEukaryotGeneExpr.v12.i3.10"},{"key":"2020021216233162500_","doi-asserted-by":"crossref","unstructured":"Shen FH, Visger JM, Balian G, Hurwitz SR, Diduch DR. Systemically administered mesenchymal stromal cells transduced with insulin-like growth factor-I localize to a fracture site and potentiate healing. J Orthop Trauma. 2002;16: 651-659.","DOI":"10.1097\/00005131-200210000-00007"},{"key":"2020021216233162500_REF8","doi-asserted-by":"crossref","unstructured":"Dominici M, Pritchard C, Garlits JE, Hofmann TJ, Persons DA, Horwitz EM. Hematopoietic cells and osteoblasts are derived from a common marrow progenitor after bone marrow transplantation. Proc Natl Acad Sci U S A. 2004;101: 11761-11766.","DOI":"10.1073\/pnas.0404626101"},{"key":"2020021216233162500_REF9","doi-asserted-by":"crossref","unstructured":"Horwitz EM, Gordon PL, Koo WK, et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci U S A. 2002;99: 8932-8937.","DOI":"10.1073\/pnas.132252399"},{"key":"2020021216233162500_REF10","doi-asserted-by":"crossref","unstructured":"Murry CE, Soonpaa MH, Reinecke H, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature. 2004;428: 664-668.","DOI":"10.1038\/nature02446"},{"key":"2020021216233162500_REF11","doi-asserted-by":"crossref","unstructured":"Wehner T, Bontert M, Eyupoglu I, et al. Bone marrow-derived cells expressing green fluorescent protein under the control of the glial fibrillary acidic protein promoter do not differentiate into astrocytes in vitro and in vivo. J Neurosci. 2003;23: 5004-5011.","DOI":"10.1523\/JNEUROSCI.23-12-05004.2003"},{"key":"2020021216233162500_REF12","doi-asserted-by":"crossref","unstructured":"Machein MR, Renninger S, de Lima-Hahn E, Plate KH. Minor contribution of bone marrow-derived endothelial progenitors to the vascularization of murine gliomas. Brain Pathol. 2003;13: 582-597.","DOI":"10.1111\/j.1750-3639.2003.tb00487.x"},{"key":"2020021216233162500_REF13","doi-asserted-by":"crossref","unstructured":"Wagers AJ, Sherwood RI, Christensen JL, Weissman IL. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science. 2002;297: 2256-2259.","DOI":"10.1126\/science.1074807"},{"key":"2020021216233162500_REF14","doi-asserted-by":"crossref","unstructured":"Wagers AJ, Weissman IL. Plasticity of adult stem cells. Cell. 2004;116: 639-648.","DOI":"10.1016\/S0092-8674(04)00208-9"},{"key":"2020021216233162500_REF15","doi-asserted-by":"crossref","unstructured":"Camargo FD, Chambers SM, Goodell MA. Stem cell plasticity: from transdifferentiation to macrophage fusion. Cell Prolif. 2004;37: 55-65.","DOI":"10.1111\/j.1365-2184.2004.00300.x"},{"key":"2020021216233162500_","doi-asserted-by":"crossref","unstructured":"Eisenberg LM, Eisenberg CA. Stem cell plasticity, cell fusion, and transdifferentiation. Birth Defects Res Part C Embryo Today. 2003;69: 209-218.","DOI":"10.1002\/bdrc.10017"},{"key":"2020021216233162500_REF17","doi-asserted-by":"crossref","unstructured":"Shi D, Reinecke H, Murry CE, Torok-Storb B. Myogenic fusion of human bone marrow stromal cells, but not hematopoietic cells. Blood. 2004;104: 290-294.","DOI":"10.1182\/blood-2003-03-0688"},{"key":"2020021216233162500_REF18","doi-asserted-by":"crossref","unstructured":"Kalajzic I, Kalajzic Z, Kaliterna M, et al. Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage. J Bone Miner Res. 2002;17: 15-25.","DOI":"10.1359\/jbmr.2002.17.1.15"},{"key":"2020021216233162500_REF19","doi-asserted-by":"crossref","unstructured":"Kalajzic I, Staal A, Yang WP, et al. Expression profile of osteoblast lineage at defined stages of differentiation. J Biol Chem. 2005;280: 24618-24626.","DOI":"10.1074\/jbc.M413834200"},{"key":"2020021216233162500_REF20","doi-asserted-by":"crossref","unstructured":"Jiang X, Kalajzic Z, Maye P, et al. Histological analysis of GFP expression in murine bone. J Histochem Cytochem. 2005;53: 593-602.","DOI":"10.1369\/jhc.4A6401.2005"},{"key":"2020021216233162500_REF21","doi-asserted-by":"crossref","unstructured":"Bilic-Curcic I, Kronenberg M, Bellizzi J, Jiang X, Gardiner E, Rowe D. Visualizing levels of osteoblast differentiation by a two color promoter-GFP strategy: type I collagen-GFPcyan and osteocalcin-GFPtpz. Genesis. 2005;43: 87-98.","DOI":"10.1002\/gene.20156"},{"key":"2020021216233162500_REF22","doi-asserted-by":"crossref","unstructured":"Visnjic D, Kalajzic I, Gronowicz G, et al. Conditional ablation of the osteoblast lineage in Col2.3deltatk transgenic mice. J Bone Miner Res. 2001;16: 2222-2231.","DOI":"10.1359\/jbmr.2001.16.12.2222"},{"key":"2020021216233162500_REF23","doi-asserted-by":"crossref","unstructured":"Visnjic D, Kalajzic Z, Rowe DW, Katavic V, Lorenzo J, Aguila HL. Hematopoiesis is severely altered in mice with an induced osteoblast deficiency. Blood. 2004;103: 3258-3264.","DOI":"10.1182\/blood-2003-11-4011"},{"key":"2020021216233162500_REF24","doi-asserted-by":"crossref","unstructured":"Wang Y-H, Liu Y, Buhl K, Rowe D. Assessment of the action of transient and continuous PTH on primary osteoblast cultures expressing differentiation stage-specific GFP. J Bone Min Res. 2005;20: 5-11.","DOI":"10.1359\/JBMR.041016"},{"key":"2020021216233162500_REF25","doi-asserted-by":"crossref","unstructured":"Chen XD, Qian HY, Neff L, Satomura K, Horowitz MC. Thy-1 antigen expression by cells in the osteoblast lineage. J Bone Miner Res. 1999;14: 362-375.","DOI":"10.1359\/jbmr.1999.14.3.362"},{"key":"2020021216233162500_REF26","doi-asserted-by":"crossref","unstructured":"Robey PG, Termine JD. Human bone cells in vitro. Calcif Tissue Int. 1985;37: 453-460.","DOI":"10.1007\/BF02557826"},{"key":"2020021216233162500_REF27","doi-asserted-by":"crossref","unstructured":"Galotto M, Berisso G, Delfino L, et al. Stromal damage as consequence of high-dose chemo\/radiotherapy in bone marrow transplant recipients. Exp Hematol. 1999;27: 1460-1466.","DOI":"10.1016\/S0301-472X(99)00076-4"},{"key":"2020021216233162500_REF28","doi-asserted-by":"crossref","unstructured":"Jackson KA, Snyder DS, Goodell MA. Skeletal muscle fiber-specific green autofluorescence: potential for stem cell engraftment artifacts. Stem Cells. 2004;22: 180-187.","DOI":"10.1634\/stemcells.22-2-180"},{"key":"2020021216233162500_REF29","doi-asserted-by":"crossref","unstructured":"Krebsbach PH, Kuznetsov SA, Satomura K, Emmons RV, Rowe DW, Robey PG. Bone formation in vivo: comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. Transplantation. 1997;63: 1059-1069.","DOI":"10.1097\/00007890-199704270-00003"},{"key":"2020021216233162500_REF30","doi-asserted-by":"crossref","unstructured":"Krebsbach PH, Mankani MH, Satomura K, Kuznetsov SA, Robey PG. Repair of craniotomy defects using bone marrow stromal cells. Transplantation. 1998;66: 1272-1278.","DOI":"10.1097\/00007890-199811270-00002"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/10\/3650\/1636649\/zh802205003650.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/10\/3650\/1636649\/zh802205003650.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T18:03:54Z","timestamp":1586369034000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/106\/10\/3650\/20924\/Heterogeneity-of-engrafted-bonelining-cells-after"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,15]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,11,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2005-02-0582","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,15]]}}}